TXNDC5 and prostate carcinoma: Additionally, the down-expression of miRNA-124 is predicted to increase the mRNA level of TXNDC5 in desmoplastic cerebellar medulloblastoma [41], whereas TXNDC5 is increased by long-term androgen-deprivation treatment (ADT)-induced hypoxia through an miRNA-200b-dependent manner in prostate cancer [2,42], and miRNA-92a in atherosclerosis [43].